Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Dermatology
•
General Dermatology
Does treatment with IL-23 inhibitors such as risankizumab (Skyrizi) impair clearance of scabies?
Related Questions
What orals or biologics do you reach for in a child with recalcitrant inverse psoriasis in the groin who has tried and failed topical including steroids, pimecrolimus, zoryve, ketoconazole, and tacrolimus?
What clinical outcomes or measures of success do you prioritize in your patients with ichthyosis?
How do you optimize retinopathy screening schedules for patients on hydroxychloroquine while also prioritizing cost-effectiveness?
What are key considerations for using monobenzone for severe vitiligo?
How do you decide whether to locally excise vs deroof a persistent draining tunnel in a patient with otherwise medically optimized HS?
What is the process for purchasing and billing Medicare for biologics used in the treatment of psoriasis?
Do you incorporate laser hair removal into your treatment plan for patients with HS?
How often, and why, do you complete disability forms for dermatologic patients?
What clinical scenarios warrant the use of a skin substitute?
What treatment do you recommend for painful large plaques of leiomyomas on the back of a patient with HLRCC syndrome when lesions are too large for excision?
